[Recommendations for the clinical use of cardiac natriuretic peptides].
Emdin
Michele
M
Istituto di Fisiologia Clinica del CNR, Pisa. emdin@ifc.cnr.it
Clerico
Aldo
A
Clemenza
Francesco
F
Galvani
Marcello
M
Latini
Roberto
R
Masson
Serge
S
Mulè
Paolo
P
Panteghini
Mauro
M
Valle
Roberto
R
Zaninotto
Martina
M
Ganau
Antonello
A
Mariotti
Rita
R
Volpe
Massimo
M
Aspromonte
Nadia
N
Cacciatore
Giuseppe
G
Cappelletti
Piero
P
L'Abbate
Antonio
A
Miglio
Federico
F
Ottani
Filippo
F
Pagani
Franca
F
Passino
Claudio
C
Plebani
Mario
M
Sarzani
Riccardo
R
Zucchelli
Giancarlo
G
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D000789:Angina, Unstable / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D009320:Atrial Natriuretic Factor / Q000097:blood*; D003937:Diagnosis, Differential; D004562:Electrocardiography; D005260:Female; D006333:Heart Failure / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012680:Sensitivity and Specificity; D013577:Syndrome; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor